neostigmine has been researched along with Atherosclerotic Parkinsonism in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kryzhanovskiĭ, GN | 2 |
| Atadzhanov, MA | 2 |
| Voronina, TA | 2 |
| Nerobkova, LN | 2 |
2 other studies available for neostigmine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
[The characteristics of a parkinsonian syndrome induced in an experiment by a deficiency of nigrostriatal dopamine and by stimulation of the cholinergic neurons of the caudate nucleus].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Acetylcholine; Animals; C | 1993 |
[Parkinson syndrome after administration of acetylcholine into the caudate nuclei].
Topics: Acetylcholine; Animals; Caudate Nucleus; Disease Models, Animal; Dopamine; Electrodes, Implanted; El | 1989 |